Hepatic fibrosis, which is important risk factor in the prognosis of NAFLD patients is related not only to traditional TGF-β pathway, but also FOSL2, ADAM17, and angiotensin pathway (24–26). The gene discussed is ADAM17; the disease is metabolic dysfunction-associated steatotic liver disease.